Retractable Technologies (RVP) Interest & Investment Income (2010 - 2026)
Retractable Technologies' (RVP) quarterly Interest & Investment Income came in at $295124.0 in Q1 2026, up 85.68% YoY from $158946.0 in Q1 2025, and up 194.46% on a QoQ basis from $100226.0 in Q4 2025.
Retractable Technologies (RVP) Interest & Investment Income (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has 17 years of Interest & Investment Income data on file, last reported at $295124.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 85.68% year-over-year to $295124.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $683539.0 (down 18.82% YoY) and the FY2025 annual result came in at $547361.0, down 45.29% from the prior year.
- Interest & Investment Income advanced to $295124.0 in Q1 2026, from $100226.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $768863.0 in Q3 2023 to a low of -$191204.0 in Q4 2022.
- A 5-year average of $196347.2 and a median of $158946.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 627.67% — and 2024, when it plunged 61.82%.
- Tracing RVP's Interest & Investment Income over 5 years: stood at -$191204.0 in 2022, then jumped by 230.4% to $249332.0 in 2023, then plunged by 41.83% to $145041.0 in 2024, then slumped by 30.9% to $100226.0 in 2025, then soared by 194.46% to $295124.0 in 2026.
- The last three Interest & Investment Income figures came in at $295124.0 (Q1 2026), $100226.0 (Q4 2025), and $147663.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 4.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 20.89 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | -119.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 3.80 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | -64.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | -64.00 Mn |
| 10 | Retractable Technologies | 21.84 Mn | -18.03 Mn | 190,852.00 | 341,164.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 295,124.00 |
| Dec 31, 2025 | 100,226.00 |
| Sep 30, 2025 | 147,663.00 |
| Jun 30, 2025 | 140,526.00 |
| Mar 31, 2025 | 158,946.00 |
| Dec 31, 2024 | 145,041.00 |
| Sep 30, 2024 | 293,550.00 |
| Jun 30, 2024 | 244,518.00 |
| Mar 31, 2024 | 317,321.00 |
| Dec 31, 2023 | 249,332.00 |
| Sep 30, 2023 | 768,863.00 |
| Jun 30, 2023 | 218,651.00 |
| Mar 31, 2023 | 209,815.00 |
| Dec 31, 2022 | -191,204.00 |
| Sep 30, 2022 | 105,661.00 |
| Jun 30, 2022 | 60,579.00 |
| Mar 31, 2022 | 73,290.00 |
| Dec 31, 2021 | -747,881.00 |
| Sep 30, 2021 | 54,911.00 |
| Jun 30, 2021 | 52,480.00 |